FLRY3.SA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:07):

Stats
Today's Volume	3.01M
Average Volume	3.13M
Market Cap	7.92B
EPS	BRL0 ( 2024-03-08 )
Next earnings date	( BRL0.310 ) 2024-05-09
Last Dividend	BRL0 ( N/A )
Next Dividend	BRL0 ( N/A )
P/E	16.70
ATR14	BRL0.0140 (0.10%)

Volume Correlation

Long: -0.02 (neutral)

Short: 0.57 (weak)

Signal:(54.024) Neutral

Fleury S.A. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fleury S.A. Correlation - Currency/Commodity

0.71
( moderate )

0.62
( weak )

0.00
( neutral )

0.60
( weak )

-0.80
( moderate negative )

-0.27
( neutral )

Fleury S.A. Financials

Annual	2023
Revenue:	BRL6.47B
Gross Profit:	BRL1.59B (24.54 %)
EPS:	BRL0.870

Q4	2023
Revenue:	BRL1.70B
Gross Profit:	BRL356.89M (20.94 %)
EPS:	BRL0.150

Q3	2023
Revenue:	BRL1.87B
Gross Profit:	BRL527.57M (28.21 %)
EPS:	BRL0.320

Q2	2023
Revenue:	BRL1.66B
Gross Profit:	BRL455.10M (27.42 %)
EPS:	BRL0.180

Financial Reports:

No articles found.

Fleury S.A.

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and image exam, diagnostic information, check-up and reference laboratory, genomics, clinic day, center of infusions, dental imaging exam, dental radiology, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including teleconsultations, medical, diagnostic medicine exams, and procedures; and corporate solutions and face-to-face primary care, as well as solutions for physicians with digital office and medical education. It operates 284 customer service units and 31 hospital-based units under the Labs a+, Felippe Mattoso, Lafe, Fleury, a+SP, CIP, Moacir Cunha, Vita, inlab, Weinmann, Serdil, a+ and Diagmax, a+, IRN / CPC, Diagnosis a+, a+BA, and Pretti and Bioclinic brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.